Selections

Aureus Asset Management, LLC does not endorse any content from third parties referenced on this site, or linked from this site.  No information displayed on this site is to be taken as investment advice.  For additional information please refer to Terms of Use for this website.

WSJ: New Weapon in Push to Lower U.S. Biotech Drug Prices

In Europe, biosimilar uptake has been slow but is starting to ramp. An acceptance of biosimilars both in the U.S. and in Europe could present cost savings for patients, though Read More

WSJ: Central Banks’ Lesson: Easy Money Alone Isn’t a Growth Salve

By IAN TALLEY Updated Sept. 17, 2015 11:20 p.m. ET As global growth continues to fall below expectations, the Federal Reserve finds it difficult to time their impending rate hike. Read More

Trader: Where to find value in the selloff

This video and description was originally posted by CNBC. Watch the video on CNBC.com Karen Firestone, Aureus Asset Management, shares her top equity plays. And Drew Matus, UBS, says U.S. consumers would Read More

Finding value in US-centric stocks: Pro

This video and description was originally posted by CNBC. Watch the video on CNBC.com Karen Firestone, Aureus Asset Management, shares her top equity plays. And Drew Matus, UBS, says U.S. Read More

Weary markets eye China and Friday’s jobs data

This video and description was originally posted by CNBC. Watch the video on CNBC.com Drew Matus, UBS, and Karen Firestone, Aureus Asset Management, share their outlook on the economy and Read More

Archive Readings and Writings